Published in Ann Thorac Surg on July 01, 2004
Chest bottle "foam" problem caused by persistent air leak: an alternative solution. Ann Thorac Surg (2006) 0.75
A simple solution to the "foam" problem. Ann Thorac Surg (2005) 0.75
Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst (2003) 3.41
Predicting outcomes in radiation oncology--multifactorial decision support systems. Nat Rev Clin Oncol (2012) 2.23
Thirty-five-year follow-up analysis of clinical and pathologic outcomes of thymoma surgery. Ann Thorac Surg (2010) 2.08
Superior vena cava replacement for lung cancer using a heterologous (bovine) prosthesis: preliminary results. J Thorac Cardiovasc Surg (2006) 1.93
Four-arm robotic lobectomy for the treatment of early-stage lung cancer. J Thorac Cardiovasc Surg (2009) 1.91
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
Alpha7-nicotinic acetylcholine receptors affect growth regulation of human mesothelioma cells: role of mitogen-activated protein kinase pathway. Cancer Res (2004) 1.77
Retracted Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatment. Am J Respir Crit Care Med (2009) 1.74
Review article: pulmonary sarcomatoid carcinomas: a practical overview. Int J Surg Pathol (2009) 1.61
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study. Lancet Oncol (2007) 1.60
Single-centre 40-year results of redo operation for recurrent thymomas. Eur J Cardiothorac Surg (2011) 1.52
Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases. Ann Thorac Surg (2007) 1.50
Long-term results after treatment for recurrent thymoma: a multicenter analysis. J Thorac Oncol (2014) 1.47
Induction therapy followed by surgery for T3-T4/N0 non-small cell lung cancer: long-term results. Ann Thorac Surg (2012) 1.46
Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem (2009) 1.41
Long-term results of endoscopic thoracic sympathectomy for upper limb hyperhidrosis. Ann Thorac Surg (2003) 1.40
Intrathoracic gastric perforation: a late complication of an unknown postpartum recurrent hiatal hernia. Interact Cardiovasc Thorac Surg (2012) 1.39
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy. Int J Radiat Oncol Biol Phys (2010) 1.25
Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med (2012) 1.24
Post-operative respiratory rehabilitation after lung resection for non-small cell lung cancer. Lung Cancer (2007) 1.21
EGFR-targeted therapy for non-small cell lung cancer: focus on EGFR oncogenic mutation. Int J Med Sci (2013) 1.14
Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma. Clin Cancer Res (2013) 1.13
Gene expression signature for angiogenic and nonangiogenic non-small-cell lung cancer. Oncogene (2005) 1.11
Early stage non-small-cell lung cancer: surgical implications of the new adenocarcinoma classification. J Thorac Oncol (2013) 1.10
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol (2002) 1.09
Pre-operative pulmonary rehabilitation and surgery for lung cancer. Lung Cancer (2007) 1.08
Combined pneumothorax and pneumoperitoneum following blunt trauma: an insidious diagnostic and therapeutic dilemma. Postgrad Med J (2011) 1.08
Are We at the Dusk of Mediastinoscopy in Modern Clinical Practice? J Thorac Oncol (2015) 1.08
Three cases of long-lasting tumor control with erlotinib after progression with gefitinib in advanced non-small cell lung cancer. J Thorac Oncol (2007) 1.07
Bronchial carcinoid tumors causing Cushing's syndrome: an insidious disease. Ann Thorac Surg (2013) 1.07
N2 nodal involvement in multiple primary lung cancer: really an exclusion criterion? Chest (2013) 1.07
Typical bronchial carcinoid tumors: focus on surgical management. Ann Thorac Surg (2012) 1.07
Malignant solitary fibrous tumors of the pleura: retrospective review of a multicenter series. J Thorac Oncol (2012) 1.07
Surgery and Survival of Patients with Diagnosis of Malignant Pleural Mesothelioma. J Thorac Oncol (2015) 1.07
A 10-year single-center experience on 708 lung metastasectomies: the evidence of the "international registry of lung metastases". J Thorac Oncol (2011) 1.06
Is it time to validate the prognostic role of F-18-FDG PET/CT scan in thymic epithelial tumors? Ann Nucl Med (2014) 1.06
Outcomes of small-cell lung cancer patients treated with second-line chemotherapy: a multi-institutional retrospective analysis. Lung Cancer (2010) 1.03
Microdrainage via open technique in severe subcutaneous emphysema. Chest (2003) 1.02
Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. Ann Thorac Surg (2012) 1.01
Tumor necrosis factor receptor-associated protein 1(TRAP1) regulates genes involved in cell cycle and metastases. Cancer Lett (2010) 1.01
The cholinergic system and cancer. Semin Cancer Biol (2007) 1.00
Successful early treatment of Boerhaave's syndrome by endoscopic placement of a temporary self-expandable plastic stent without fluoroscopy. Gastrointest Endosc (2003) 1.00
A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme. Int J Surg Pathol (2006) 1.00
Natural History of Non-Small-Cell Lung Cancer with Bone Metastases. Sci Rep (2015) 0.99
Chest wall giant lipoma with a thirty-year history. Interact Cardiovasc Thorac Surg (2012) 0.99
Dual role of RASSF1 as a tumor suppressor and an oncogene in neuroendocrine tumors of the lung. Anticancer Res (2010) 0.98
Natural agents targeting the alpha7-nicotinic-receptor in NSCLC: a promising prospective in anti-cancer drug development. Int J Cancer (2008) 0.98
Paraneoplastic acrokeratosis (bazex syndrome) in lung cancer. J Clin Oncol (2009) 0.98
alpha7-Nicotinic receptor antagonists at the beginning of a clinical era for NSCLC and Mesothelioma? Drug Discov Today (2009) 0.97
Phase I trial of weekly gemcitabine and concurrent radiotherapy in patients with inoperable non-small-cell lung cancer. J Clin Oncol (2002) 0.97
Nicotine, lung and cancer. Anticancer Agents Med Chem (2007) 0.97
Nicotine: specific role in angiogenesis, proliferation and apoptosis. Crit Rev Toxicol (2011) 0.96
PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids. Tumour Biol (2014) 0.95
Post-esophagectomy anastomotic leaks. The role of the anastomotic location. Ann Ital Chir (2013) 0.95